A bibliometric study of the top 100 most-cited articles on melanoma: insights into research trends and characteristics
Year: 2025
Type: article
Abstract: Improving insights into current research and literature on melanoma enables healthcare providers to offer patients better care by applying the latest advancements. This bibliometric study analyzed the characteristics and trends in melanoma research through the top-cited articles. The top 100 most-cited articles on melanoma were published between 1969 and 2020, and the average number of citations was 36.8-893.9 (mean 176.8). Notably, the frequencies of the main key words, including antineoplastic agents, genetics, randomized controlled trials, metastatic melanoma, BRAF, and monoclonal antibodies, during 2010-2020 were significantly higher than during 1969-2009. Specifically, the main study topics after 2010 were drug research aspects, such as drug safety, drug efficacy, drug resistance, drug withdrawal, cytotoxic T lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1/programmed death-ligand 1 (PD-1/PD-L1), ipilimumab, nivolumab, trametinib, dabrafenib, vemurafenib, and various drug adverse effects. The emergence of immunotherapy caused a burst of citations and substantially changed the distribution of top-cited articles.
Source: Dermatology Reports
Authors: Jinhao Zhang, Xiangze Meng, Yun Wang, Wei Liu
Language: English
Subfield: Statistics, Probability and Uncertainty
Field: Decision Sciences
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $539
OpenAlex ID: W4413289148